Latest Board Renewal News

Sequoia Financial Group reported a robust FY25 with a 13.7% rise in EBITDA and a 44% jump in funds under advice, underpinned by strategic restructuring and technology investments.

Mineral Resources Limited reported FY25 results highlighting record mining services earnings driven by Onslow Iron's ramp-up, offset by lithium challenges and significant impairments. The company is focused on deleveraging and strengthening governance as it transitions to long-life, low-cost assets.

Mineral Resources Limited reports a challenging FY25 marked by lithium price volatility and operational hurdles, but highlights strong progress at Onslow Iron and a strategic focus on governance and deleveraging.

Mineral Resources Limited posted a $896 million statutory loss for FY25, driven by significant impairments, while Onslow Iron achieved commercial production and governance reforms reshape the board.

AI-Media Technologies marked FY25 as a pivotal year, transitioning to a technology-led business with 63% of revenue from tech products and launching LEXI Voice. The company expanded its global footprint to 36 countries and set ambitious targets for FY29.

IGO Limited reported a significant net loss for FY25 driven by a $605 million impairment at its Kwinana lithium refinery and challenging market conditions. Despite setbacks, the Greenbushes operation maintained strong margins, and the company is advancing a refreshed strategy focused on clean energy materials.

Adairs Limited reported a 6.5% increase in FY25 group sales to $618.1 million, driven by strong growth in Adairs and Mocka brands, while Focus on Furniture faced challenges. The company’s new CEO Elle Roseby has initiated a strategic reset and sustainability initiatives to position the group for long-term growth.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.

Kogan.com announces the appointment of three seasoned independent directors as part of a strategic board renewal, while confirming a planned chairman transition in 2026.

Genetic Signatures reported a 63% revenue increase to $15.9 million in FY25, alongside a 28% reduction in underlying losses and a strategic shift in its automated diagnostics platform development.

Genetic Signatures Limited reported a 63% revenue surge to $15.9 million in FY25, driven by strong Australian sales and progress in EMEA, while navigating a $20.1 million net loss and a strategic pivot towards partnerships for automated diagnostics.

Data # 3 Limited has delivered a robust FY25 performance with revenues rising 5.8% to $863 million and net profit up 11.3%, supported by strong growth across its core business segments and a 10.2% dividend increase.